ARCHIVES

FDA Approves Velcade For Treatment Of Refractory Multiple Myeloma

This article is from The Cancer Letter archive.

Vol. 26 No. 5 | May 30, 2003

Download PDF Visit The Full Archive

Related Articles

Paul Goss, Patricia Ganz Discuss Breast Cancer Prevention Trials.

April 20, 2007

FDA Considering Ways To Improve Process Of Secondary Approvals Of Cancer Drugs

November 1, 1991

NCI-Approved Clinical Trials

December 30, 2005

Reinventing NCI: Natural Products Screen Closes; NCI Targets Drug Resistance

December 13, 1996

Howard Hughes Medical Institute Appoints 12 Physician Investigators

May 31, 2002

Proteomics Promises Ways To Track Response To Therapy

April 25, 2003